Related Experiment Video
Updated: Aug 12, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Quantitative thallium-201 single-photon emission computed tomography during maximal pharmacologic coronary
S Nishimura1, J J Mahmarian, T M Boyce
1Department of Internal Medicine, Baylor College of Medicine, Houston, Texas.
Insights
Quantitative thallium-201 SPECT combined with adenosine infusion effectively diagnoses coronary artery disease. This method accurately identifies stenosis and affected regions, even in multivessel disease cases.
Area of Science:
- Cardiology
- Nuclear Medicine
- Diagnostic Imaging
Background:
- Coronary artery disease (CAD) diagnosis relies on invasive and non-invasive methods.
- Pharmacologic stress testing enhances the diagnostic accuracy of myocardial perfusion imaging.
- Adenosine-induced vasodilation is a key pharmacologic stressor in SPECT imaging.
Purpose of the Study:
- To evaluate the diagnostic accuracy of thallium-201 SPECT with adenosine infusion for detecting CAD.
- To assess the sensitivity and specificity of quantitative analysis and polar maps in identifying coronary stenoses.
- To correlate perfusion defect extent with the severity of coronary artery disease.
Main Methods:
- 101 patients with suspected CAD underwent thallium-201 SPECT during maximal pharmacologic vasodilation with intravenous adenosine.
- Coronary arteriography was performed concurrently for gold-standard comparison.
- Tomographic images were analyzed visually and quantitatively using computer-generated polar maps.
Main Results:
- Quantitative thallium-201 SPECT demonstrated high sensitivity (87%) and specificity (90%) for detecting CAD (defined as >50% stenosis).
- Sensitivity was particularly high in patients with prior myocardial infarction (96%) and varied by vessel involvement (76%-90%).
- The extent of perfusion defects on polar maps correlated directly with the extent of coronary artery disease.
Conclusions:
- Quantitative thallium-201 SPECT during adenosine infusion is a sensitive and specific tool for diagnosing CAD.
- This technique effectively localizes coronary stenoses and identifies affected vascular regions, including in multivessel disease.
- The findings support the use of adenosine stress thallium-201 SPECT for comprehensive CAD assessment.
Abstract:
The diagnostic value of maximal pharmacologic coronary vasodilation with intravenously administered adenosine in conjunction with thallium-201 single-photon emission computed tomography (SPECT) for detection of coronary artery disease was investigated in 101 consecutive patients who had concomitant coronary arteriography. Tomographic images were assessed visually and from computer-quantified polar maps of the thallium-201 distribution. Significant coronary artery disease, defined as greater than 50% luminal diameter stenosis, was present in 70 patients. The sensitivity for detecting patients with coronary artery disease using quantitative analysis was 87% in the total group, 82% in patients without myocardial infarction and 96% in those with prior myocardial infarction; the specificity was 90%. The sensitivity for diagnosing coronary artery disease in patients without infarction with single-, double-and triple-vessel disease was 76%, 86% and 90%, respectively. All individual stenoses were identified in 68% of patients with double-vessel disease and in 65% of those with triple-vessel disease. The extent of the perfusion defects, as quantified by polar maps, was directly related to the extent of coronary artery disease. In conclusion, quantitative thallium-201 SPECT during adenosine infusion has high sensitivity and specificity for diagnosing the presence of coronary artery disease, localizing the anatomic site of coronary stenosis and identifying the majority of affected vascular regions in patients with multivessel involvement.
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies

